Astex Pharmaceuticals (ASTX)
Add to Watchlists Create an Alert
5.36
+0.24 +4.69%
NASDAQ
May 24, 8:00PM
BATS Real time
Currency in USD
Astex Pharmaceuticals Net Income Quarterly:
0.488M for Dec. 31, 2012Astex Pharmaceuticals Historical Net Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 0.488M |
| Dec. 31, 2012 | 4.527M |
| Sept. 30, 2012 | -1.76M |
| June 30, 2012 | 1.239M |
| March 31, 2012 | 4.24M |
| Dec. 31, 2011 | 0.22M |
| Sept. 30, 2011 | -1.071M |
| June 30, 2011 | 0.903M |
| March 31, 2011 | 5.49M |
| Dec. 31, 2010 | 6.746M |
| Sept. 30, 2010 | 3.892M |
| June 30, 2010 | 0.961M |
| March 31, 2010 | 4.674M |
| Dec. 31, 2009 | 2.336M |
| Sept. 30, 2009 | 0.833M |
| June 30, 2009 | -2.427M |
| March 31, 2009 | 3.994M |
| Dec. 31, 2008 | -2.593M |
| Sept. 30, 2008 | -0.569M |
| June 30, 2008 | -4.879M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.
Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More
ASTX Net Income Quarterly Benchmarks
| Companies | |
|---|---|
| AcelRx Pharmaceuticals | -10.52M |
| GlaxoSmithKline | 1.460B |
| Raptor Pharmaceutical | -15.93M |
ASTX Net Income Quarterly Rankings
| Overall |
59th percentile 3212 of 8011 |
| Sector |
67th percentile 226 of 687 in Healthcare |
| Industry |
70th percentile 16 of 55 in Drug Manufacturers - Major |
ASTX Net Income Quarterly Range, Past 5 Years
| Minimum | -4.879M | Jun 2008 |
| Maximum | 6.746M | Dec 2010 |
| Average | 1.362M |
ASTX News
Astex Pharmaceuticals' CEO Presents at UBS Global Healthcare Conference (Transcript)
Seeking Alpha May 20
Seeking Alpha May 20